Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-06-20 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2022年向特定对象发行股票预案（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "2022 年向特定对象发行股票预案（修订稿）" which translates to "2022 Proposal for Private Placement of Shares (Revised Draft)" by 盈康生命科技股份有限公司. It discusses the company's plan to issue shares to a specific object (private placement), including details about the issuance background, purpose, pricing, number of shares, regulatory approvals required (China Securities Regulatory Commission, Shenzhen Stock Exchange), and related legal and financial considerations. The document is comprehensive and contains detailed financial and operational analysis related to the capital raising activity. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an announcement of a report, nor a full annual or interim report, but a detailed plan and proposal for a capital issuance. Therefore, the correct classification is CAP with high confidence.
2023-06-20 Chinese
截至2023年3月31日前次募集资金使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "前次募集资金使用情况鉴证报告" which translates to "Verification Report on the Use of Previous Fundraising Proceeds". It is issued by an accounting firm and includes detailed information about the use of funds raised in a previous private placement, including amounts raised, usage, remaining balances, and compliance with regulatory guidelines issued by the China Securities Regulatory Commission. The document contains financial data and an auditor's verification conclusion. This type of report is a specialized audit or verification report on the use of capital raised, not a full annual or interim financial report. It is not an announcement or a brief summary but a detailed verification report. Therefore, it fits best under the category Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial matters such as fundraising usage verification. Q1 2023
2023-06-20 Chinese
2022年向特定对象发行股票募集资金使用可行性分析报告（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金使用可行性分析报告（修订稿）" which translates to "Feasibility Analysis Report on the Use of Raised Funds" related to a specific stock issuance to particular investors. It discusses the company's plan to raise funds through a targeted stock issuance, the necessity and feasibility of using the raised funds, the impact on the company's financial and operational status, and compliance with relevant laws and regulations. The document is focused on the capital raising activity and the use of proceeds, rather than being a general financial report or earnings release. It is not an announcement of the issuance but a detailed feasibility analysis report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is 3279 characters, which is sufficient for a detailed report rather than a brief announcement. Therefore, the classification is CAP with high confidence.
2023-06-20 Chinese
关于召开2023年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice for the convening of the 2023 second extraordinary general meeting (临时股东大会) of the company 盈康生命科技股份有限公司. It includes information about the meeting date, voting procedures, proposals to be voted on, and instructions for shareholders. The content focuses on the announcement and procedural details of a shareholder meeting rather than the meeting materials or results. It does not contain financial statements or detailed financial analysis. Therefore, it is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2023-06-20 Chinese
关于向特定对象发行股票摊薄即期回报的风险提示及采取填补措施和相关主体承诺（修订稿）的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a company's plan to issue new shares to specific investors, including analysis of the dilution impact on immediate returns, risk warnings, measures to mitigate dilution, and commitments from controlling shareholders and management. It references regulatory guidelines and includes financial assumptions and projections related to the issuance. The content focuses on the capital raising activity and its financial impact rather than presenting a full financial report or earnings release. The document length is over 6,000 characters and contains substantive financial data and analysis related to the issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2023-06-20 Chinese
第五届董事会第三十三次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of 盈康生命科技股份有限公司 (Yingkang Life Technology Co., Ltd.) held on June 20, 2023. It includes multiple agenda items related to a proposed private placement of shares to a specific investor, including approval of the issuance plan, feasibility analysis, dilution impact and compensation measures, previous fundraising usage report, and scheduling of a subsequent extraordinary shareholders meeting to approve these matters. The document references compliance with Chinese securities laws and regulations and mentions that the proposals will be submitted to the shareholders for approval. The content is focused on board decisions and corporate governance matters related to capital raising and shareholder meetings. It is not a full financial report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement, but rather a board meeting resolution announcement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3669 characters, which is sufficient for a detailed board meeting resolution announcement, not a brief report publication announcement or regulatory filing.
2023-06-20 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.